Evidence map›Paper›PMID 32138344›Full record

Trial reportNutrients2020

A randomized Placebo-Controlled Clinical Trial to Evaluate the Medium-Term Effects of Oat Fibers on Human Health: The Beta-Glucan Effects on Lipid Profile, Glycemia and inTestinal Health (BELT) Study.

Arrigo F G Cicero, Federica Fogacci, Maddalena Veronesi, Enrico Strocchi, Elisa Grandi, Elisabetta Rizzoli, Andrea Poli, Franca Marangoni, Claudio Borghi

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Nutrients, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
7.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 100 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Noninvasive instrumental evaluation of coenzyme QBioFactors (Oxford, England) · 2022
    Trial
  10. Trial
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Effect of Coenzyme QJournal of clinical medicine · 2024
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Arrigo F G CiceroAtherosclerosis and Hypertension Research Group, Medical and Surgical Sciences Department, Sant'Orsola-Malpighi University Hospital, Building 2-IV Floor, Via Albertoni 15, 40138 Bologna, Italy.ORCID 0000-0002-4367-3884
Federica FogacciAtherosclerosis and Hypertension Research Group, Medical and Surgical Sciences Department, Sant'Orsola-Malpighi University Hospital, Building 2-IV Floor, Via Albertoni 15, 40138 Bologna, Italy.ORCID 0000-0001-7853-0042
Maddalena VeronesiAtherosclerosis and Hypertension Research Group, Medical and Surgical Sciences Department, Sant'Orsola-Malpighi University Hospital, Building 2-IV Floor, Via Albertoni 15, 40138 Bologna, Italy.
Enrico StrocchiAtherosclerosis and Hypertension Research Group, Medical and Surgical Sciences Department, Sant'Orsola-Malpighi University Hospital, Building 2-IV Floor, Via Albertoni 15, 40138 Bologna, Italy.
Elisa GrandiAtherosclerosis and Hypertension Research Group, Medical and Surgical Sciences Department, Sant'Orsola-Malpighi University Hospital, Building 2-IV Floor, Via Albertoni 15, 40138 Bologna, Italy.
Elisabetta RizzoliAtherosclerosis and Hypertension Research Group, Medical and Surgical Sciences Department, Sant'Orsola-Malpighi University Hospital, Building 2-IV Floor, Via Albertoni 15, 40138 Bologna, Italy.
Andrea PoliNutrition Foundation of Italy, Viale Tunisia 38, 20124 Milan, Italy.
Franca MarangoniNutrition Foundation of Italy, Viale Tunisia 38, 20124 Milan, Italy.ORCID 0000-0003-3590-2330
Claudio BorghiAtherosclerosis and Hypertension Research Group, Medical and Surgical Sciences Department, Sant'Orsola-Malpighi University Hospital, Building 2-IV Floor, Via Albertoni 15, 40138 Bologna, Italy.
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola · IT

Funding

undefined <span style="color:gray;font-size:10px;">undefined</span> BELT 2018
6 · The paper itself

Abstract

The Beta-glucan Effects on Lipid profile, glycemia and inTestinal health (BELT) Study investigated the effect of 3 g/day oat beta-glucans on plasma lipids, fasting glucose and self-perceived intestinal well-being. The Study was an 8-week, double-blind, placebo-controlled, cross-over randomized clinical trial, enrolling a sample of 83 Italian free-living subjects, adherent to Mediterranean diet, with a moderate hypercholesterolemia and a low cardiovascular risk profile. Beta-glucans reduced mean LDL-Cholesterol (LDL-C) levels from baseline by 12.2% (95%CI: -15.4 to -3.8) after 4 weeks of supplementation and by 15.1% (95%CI: -17.8 to -5.9) after 8 weeks of supplementation (

Indexed as

AvenaHypercholesterolemiaAdultAgedbeta-GlucansBlood GlucoseCross-Over StudiesDietary FiberDouble-Blind MethodFastingFemaleHumansLipidsMaleMiddle Agedbeta-GlucansBlood GlucoseDietary FiberLipidsbeta-glucancholesterolfiberintestinal functionlipid profile

Identifiers

PMID32138344
PMCPMC7146517
OpenAlexW3009235808

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.